# Phase 2A Closeout Report

## Status

CLOSED - PRODUCT OWNER ACCEPTED

## Phase

Phase 2A - Local AI Platform Consolidation

## Reporting Date

2026-07-09

## Product Owner Acceptance

Accepted on 2026-07-09.

## Executive Summary

Phase 2A consolidated the provider-neutral Local AI platform established during
Phase 1B while preserving the SAFE integration path and existing governance
boundaries.

The SAFE bridge now enters the subsystem through `LocalAIManager`. Ollama and
LM Studio satisfy one shared provider contract. A Provider Development Kit,
certification checklist, code template, and certified reference provider now
define a repeatable extension model.

The full regression suite contains 131 passing tests. No LOCKED component was
modified by the Phase 2A milestones.

## Objectives and Outcomes

| Objective | Outcome |
| --------- | ------- |
| Make `LocalAIManager` the SAFE bridge entry point | COMPLETE |
| Preserve LocalSolver output schema and behavior | VERIFIED |
| Establish shared provider contract tests | COMPLETE |
| Standardize provider development and certification | COMPLETE |
| Prove provider extensibility | COMPLETE |
| Preserve public contracts | VERIFIED |
| Preserve provider neutrality and provenance-only identity | VERIFIED |
| Preserve LOCKED boundaries | VERIFIED |

## Milestone Summary

| Milestone | Result | Evidence |
| --------- | ------ | -------- |
| Commencement | PASS | VE-001 |
| M1 SAFE bridge convergence design | PASS | VE-002 |
| M2 SAFE bridge convergence | PASS | VE-003 |
| M3 shared provider contract | PASS | VE-004 |
| M4 Provider Development Kit | PASS | VE-005 |
| M5 reference provider certification | PASS | VE-006 |
| M6 platform extension validation | PASS | VE-007 |

## Verification

The evidence records show regression growth from 124 tests after bridge
convergence to 131 tests after reference-provider certification.

Final recorded regression:

```text
Ran 131 tests
OK
```

Verification confirms:

- no LocalSolver output schema change;
- no confidence, score, authority, rank, or vote-weight change;
- no provider ranking;
- provider and model identity remain provenance only;
- no runtime registry exposure for the reference provider;
- no LOCKED component modification.

## Governance Compliance

Phase 2A remained within its authorization:

- non-LOCKED Local AI subsystem work only;
- no runtime orchestration change;
- no scoring or authority change;
- no governance change;
- no cloud provider or MCP implementation.

## P2A-B003 Disposition

`P2A-B003` is deferred for evidence-driven reassessment in Phase 2B. It is not
blocking Phase 2A acceptance.

The assessment identified limited duplication in HTTP JSON transport, endpoint
validation, and elapsed-time calculation. It also confirmed that provider
health payloads, request mapping, response normalization, completion semantics,
and diagnostics remain materially different.

Extraction at this stage would introduce premature coupling without measurable
benefit. It is not required for manager ownership, provider interchangeability,
shared contract compliance, PDK usability, or extension validation.

Phase 2B should reassess utility extraction when a third production
transport-backed provider is proposed or measurable duplication cost emerges.

The deferral has no impact on Phase 2A objectives. Existing adapters remain
isolated and verified through the shared contract. Future reassessment shall
occur only if engineering evidence justifies additional abstraction.

## Recommendation

All Phase 2A engineering objectives and exit criteria are dispositioned.

```text
PHASE 2A CLOSED
```
